2012
DOI: 10.1016/j.surg.2011.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: Influence on serum thyroglobulin level, recurrence rate, and postoperative complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
94
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(100 citation statements)
references
References 24 publications
3
94
0
3
Order By: Relevance
“…[4][5][6] Metastatic lymph node ratio (LNR) (defined as number of metastatic lymph nodes divided by number of lymph nodes examined) after prophylactic lymphadenectomy has been shown to be a promising prognostic variable in a variety of nonthyroidal primary cancers (e.g., colorectal, gastric, and pancreatic cancers). [7][8][9] The concept of LNR is based on the assumption that it indirectly reflects the extent who did not (100% vs. 39.1%, P = 0.013).…”
mentioning
confidence: 99%
“…[4][5][6] Metastatic lymph node ratio (LNR) (defined as number of metastatic lymph nodes divided by number of lymph nodes examined) after prophylactic lymphadenectomy has been shown to be a promising prognostic variable in a variety of nonthyroidal primary cancers (e.g., colorectal, gastric, and pancreatic cancers). [7][8][9] The concept of LNR is based on the assumption that it indirectly reflects the extent who did not (100% vs. 39.1%, P = 0.013).…”
mentioning
confidence: 99%
“…was a predictor of ipsilateral central lymph node metastasis (CLNM) recommending pCND in patients with a tumor size >1 cm. DFS was not statistically different between both groups [ Table 8], as many studies comparing TT+ pCND versus TT alone didn't find a survival benefit between both groups (Sywak et al, 2006;Costa et al, 2009;Zuniga et al, 2009;So et al, 2012). The most recent controversy has been provided by Barczewski et al, 2013 who published the first paper in the literature showing a benefit not only for local recurrence (5.5% vs 12.4%) but also for specific disease survival (98% vs 92.5%) for patients with PTC having TT + pCND in comparison with those who had only TT, major bias in this study are its retrospective nature and that patients considered at risk in any group had RAI treatment.…”
Section: Discussionmentioning
confidence: 99%
“…For both children and adults with TMCs of nonpapillary histology (Hurthle cell, follicular and tallcell) or with extrathyroidal extension, strong consideration should be made for performing a TTx given the increased rate of recurrence and death in these patients [9,[18][19]. Male gender and non-White race may also influence survival and therefore influence surgical decisions.…”
Section: What Operation To Performmentioning
confidence: 99%